NM_002234.4(KCNA5):c.1497G>A (p.Leu499=) AND Atrial fibrillation, familial, 7

Clinical significance:Benign/Likely benign (Last evaluated: Nov 25, 2020)

Review status:2 stars out of maximum of 4 stars

criteria provided, multiple submitters, no conflicts

Based on:
2 submissions [Details]
Record status:
current
Accession:
RCV000535336.6

Allele description [Variation Report for NM_002234.4(KCNA5):c.1497G>A (p.Leu499=)]

NM_002234.4(KCNA5):c.1497G>A (p.Leu499=)

Gene:
KCNA5:potassium voltage-gated channel subfamily A member 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p13.32
Genomic location:
Preferred name:
NM_002234.4(KCNA5):c.1497G>A (p.Leu499=)
HGVS:
  • NC_000012.12:g.5045644G>A
  • NG_012198.1:g.6726G>A
  • NM_002234.4:c.1497G>AMANE SELECT
  • NP_002225.2:p.Leu499=
  • NC_000012.11:g.5154810G>A
  • NM_002234.3:c.1497G>A
Links:
dbSNP: rs17221805
NCBI 1000 Genomes Browser:
rs17221805
Molecular consequence:
  • NM_002234.4:c.1497G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Atrial fibrillation, familial, 7 (ATFB7)
Identifiers:
MONDO: MONDO:0012828; MedGen: C2677106; OMIM: 612240

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000646978Invitaecriteria provided, single submitter
Benign
(Nov 25, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001270764Illumina Clinical Services Laboratory,Illuminacriteria provided, single submitter
Likely benign
(Jun 7, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Polymorphism screening in the cardiac K+ channel gene KCNA5.

Simard C, Drolet B, Yang P, Kim RB, Roden DM.

Clin Pharmacol Ther. 2005 Mar;77(3):138-44.

PubMed [citation]
PMID:
15735608

Details of each submission

From Invitae, SCV000646978.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Illumina Clinical Services Laboratory,Illumina, SCV001270764.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 14, 2021

Support Center